ANNA SHAW: Open Payments
NPI 1265763676 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 29 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $325 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 1 | $133 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
| Regeneron Healthcare Solutions, Inc. | 3 | $100 |
| ABBVIE INC. | 5 | $83 |
| Amgen Inc. | 3 | $64 |
| GENZYME CORPORATION | 1 | $40 |
| Lilly USA, LLC | 2 | $39 |
| UCB, Inc. | 1 | $38 |
| REVANCE THERAPEUTICS, INC. | 1 | $33 |
| Botanix SB Inc | 1 | $26 |
Products named: DUPIXENT, FUROSCIX, COSENTYX, SKYRIZI, OTEZLA, TALTZ, Bimzelx, DAXXIFY.
Industry payments across FL — which companies pay providers there.
